Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

VI.d

Pulmonary vasculitis or capillaritis

Publications

Tazelaar HD, Myers JL, Strickler JG, Colby TV, Duffy J

Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1993;6(1):56-60

Campagna AC, Blanc PD, Criswell LA, Clarke D, Sack KE, Gold WM, Golden JA

Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion.

Chest. 1992;101(5):1274-81